AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Cardium Therapeutics (NYSE Amex: CXM), San Diego, has reported highlights and financial results for its fourth quarter and fiscal year ended December 31, 2008, and other important recent developments and outlook for 2009.
Recent Developments and 2009 Outlook
Cardium's business is focused on the acquisition and strategic development of product opportunities or businesses having the potential to address significant unmet medical needs, and definable pathways to commercialization, partnering or other monetization. As our product opportunities and businesses are advanced and corresponding valuations established, we intend to consider various corporate ...
Source: HighBeam Research, CARDIUM HIGHLIGHTS/FINANCIAL RESULTS AND 2009 OUTLOOK.